Back to STATE STREET CORP STATE STREET CORP

ZBIOZBIO
7 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ZENAS BIOPHARMA INC

Yes. State Street holds 2,055,100 shares of ZBIO (Zenas Biopharma), worth $52.2M, as of its Q2 2026 13F filing. It increased the position by 584,177 shares (+39.7%) from Q1 2026. State Street has held ZBIO since Q4 2024, across 7 quarterly 13F filings.

Current Value

$52.2M

Current Shares

2.1M

Total Value Change

+$50.4M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+39.7%
$52.2M0.0%$25.38
39
2026-Q1
Increased
1.5M
+235.6%
$28.8M0.0%$25.18
46
2025-Q4
Increased
438,294
+16.1%
$15.9M0.0%$36.58
33
2025-Q3
Increased
377,485
+21.7%
$8.4M0.0%$20.57
33
2025-Q2
Increased
310,236
+16.5%
$3M0.0%$9.58
31
2025-Q1
Increased
266,200
+25.9%
$2.1M0.0%$8.17
32
2024-Q4
New
211,506
-
$1.7M0.0%$8.99
36

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used